Search Results

You searched for : CovidTreatment  

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ...
Mar 27

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ...
Mar 27

BioVaxys enters into a major bioproduction agreement with Wuxi Biologics (Hong Kong) Ltd.

...
Mar 16

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses

The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ...
Jan 13

Many states receive first consignment of COVID-19 vaccine

The first consignment of the COVID-19 vaccine received by several states in India...
Jan 13

DGCA issues guidelines for Airlines to transport COVID-19 vaccines

India's civil aviation regulator, the Directorate General of Civil Aviation (DGCA), has issued guidelines to airlines and other aircraft operators for transportation of Covid-...
Jan 09

Maharashtra: All arrangements made for Covid-19 vaccination dry run today

State Health Minister, Rajesh Tope said that the dry run will be conducted at three healthcare centers in each district and one center in municipal ...
Jan 08

COVID-19 vaccine ‘Covaxin’ marks a significant milestone: Karnataka Health Minister

Karnataka Minister for Health and Medical Education Dr. K. Sudhakar has come forward to negate suspicion on the Covaxin vaccine developed by Bharat Biotech....
Jan 05

Covid 19 vaccines introduced in India will be as effective as developed by other countries: Govt

The government has said that the Covid-19 vaccines introduced in India will be as effective as any vaccine developed by other countries. ...
Jan 04

Medical experts welcome govt's decision to approve two Corona vaccines for emergency use in country

All India Institute of Medical Sciences (AIIMS) Director Dr. Randeep Singh Guleria has lauded the work done by Indian laboratories in making indigenous vaccines....
Jan 04

India approves AstraZeneca's COVID-19 vaccine

India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunization campaign in the world’s ...
Jan 02

RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib

Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material ...
Jan 02

The RedHill Phase II / III candidate opaganib reduces ARDS-related blood clotting in the preclinical model in COVID-19 patients

The results also show that opaganib inhibits SARS-CoV-2 virus replication and proinflammatory markers in relevant preclinical models ...
Dec 17

Incyte announces results of phase 3 RUXCOVID study of Ruxolitinib as a treatment for patients with COVID-19 associated cytokine storm

The data will be further analyzed to determine any potential impact on other studies of ruxolitinib in patients with COVID-19, and will be submitted ...
Dec 15

PureTech starts phase 2 trial of LYT-100 in long COVID-19 respiratory complications and related sequelae

PureTech’s global, randomized, double-blind, placebo-controlled Phase 2 trial is designed to evaluate the efficacy, safety and tolerability of LYT-100 in adults ...
Dec 05

Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India

Zydus Cadila, had received an approval from the Drugs Controller General of India to start the Phase 3 clinical trial in COVID-19 patients with ...
Dec 04

Roche receives USFDA emergency use authorization for new test to measure the level of SARS-CoV-2 antibodies

This test may help identify recovering patients who could potentially be serum and plasma donors for developing treatments for COVID-19...
Dec 03

Colchicine could serve as treatment for outpatients of COVID-19: MHI

COLCORONA is a non-contact, home, randomized, double-blind, placebo-controlled study conducted in Canada, the United States, Europe, South America, and South Africa...
Nov 30

ARCA biopharma receives U.S. FDA fast track designation for AB201 as a potential treatment for COVID-19

ARCA believes that AB201 is the only anticoagulant class new chemical entity in development for COVID-19 that has a Fast Track designation...
Nov 24

Regeneron's REGEN-COV2 is first antibody cocktail for COVID-19 to receive US FDA emergency use authorization

The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ...
Nov 23

AbCellera-discovered antibody granted interim authorization by health Canada as a treatment for COVID-19

Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020...
Nov 23

RedHill announces DSMB unanimous recommendation to continue COVID-19 opaganib phase 2/3 study

The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia...
Nov 23

WHO Guideline Development Group advises against use of remdesivir for covid-19

Currently no evidence that it improves survival and other important measures ...
Nov 20

India's indigenous solution to COVID-19 in progress

Monoclonal antibody leads for COVID-19: A way forward In combating COVID-19 ...
Nov 19

Fluvoxamine an antidepressant drug may help prevent severe COVID-19

Researchers say, fluvoxamine may be having beneficial effects by some other mechanism not yet understood...
Nov 17

25 Matching result(s) found!

-Advertisements-




Trending Now

Hospital-acquired infections are fuelling antimicrobial resistance October 30, 2024
Transforming Patient Care: HealthTech Startups Making Waves in HealthcareOctober 30, 2024
Hospital-acquired infections are fuelling antimicrobial resistance October 30, 2024
Impressive Growth & Margin Expansion 237% YoY Surge in Net ProfitsOctober 29, 2024
Ramaiah Memorial Hospital Announces the Launch of its Comprehensive State-of-the-art Ramaiah Stroke Center on World Stroke Day October 29, 2024
CarDekho Group's New Auto Segment’s Festive Trend Report: SUVs Lead the Way with a 43% YoY Traffic Increase Across All Sub-SegmentsOctober 29, 2024
World Stroke Day by Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital.October 29, 2024
HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024October 29, 2024
AI Gone Wild? Why OpenAI’s Whisper - Transcription Tool used in Hospitals Might Be Putting Lives at RiskOctober 29, 2024
India’s Humanitarian Aid to Palestine Amid Middle Eastern TurmoilOctober 29, 2024
A Race Against Time How World Stroke Day Highlights India’s Hidden Health CrisisOctober 29, 2024
Hester Biosciences Ltd Consolidated Net Profit in Q2FY25 up 108% Y-o-Y to Rs. 8.39 crore; Revenue up 19% to Rs. 83.69 croreOctober 28, 2024
Is Your Eye Surgery Safe? Inside Chhattisgarh’s Cataract Infection ScandalOctober 28, 2024
Can PM Modi’s 13,000 Crore Investment Reframe India’s Approach to Health?October 28, 2024
Herbalife India and IIT Madras Launch 1,000 Data Science Scholarships, Expanding Quality Education Access for Underserved CommunitiesOctober 28, 2024
American Oncology Institute (AOI) in Imphal Successfully Treats Advanced Thyroid Cancer CasesOctober 28, 2024
Beyond the Flare: Revolutionizing Psoriasis Care for a Brighter Tomorrow!October 28, 2024
Toxic Threat in Chennai’s Tiruvottiyur School: Inside the Mystery Gas Leak That Left Students HospitalizedOctober 26, 2024
Are You Scrolling Your Life Away? The Dark Reality of Digital AddictionOctober 26, 2024
Are You Scrolling Your Life Away? The Dark Reality of Digital AddictionOctober 26, 2024